A new strain of bird flu that emerged in China over the past month is one of the "most lethal" flu viruses so far, worrying health officials because it can jump more easily from birds to humans than the one that started killing ...
Apr 24, 2013
0
0
With the use of sophisticated mathematical modelling techniques, a mathematician at PolyU and his co-researchers have completed a study that explains the phenomenon of multiple waves of influenza pandemic in the last century.
Jul 25, 2013
0
0
The influenza virus' ability to mutate quickly has produced new, emerging strains that make drug discovery more critical than ever. For the first time, researchers at Seattle BioMed, along with collaborators at the University ...
Jul 5, 2013
0
0
A new computer model could help scientists predict when a particular strain of avian influenza might become infectious from bird to human, according to a report to be published in the International Journal Data Mining and ...
May 20, 2013
0
0
A remarkable new technology developed by Manchester biochemists has found a way to restrict the spread of flu.
Mar 17, 2016
0
7
The United States' Centers for Disease Control and Prevention (CDC) has issued a health alert after the first case of H5N1 avian influenza, or bird flu, seemingly spread from a cow to a human.
Apr 8, 2024
0
0
A belief that the seasonal flu jab really works is far more likely to sway healthcare professionals to get vaccinated than the potential to protect at risk patients from infection, finds research published in Occupational ...
Mar 7, 2012
0
0
A seasonal flu shot is a bit like a local weather forecast: Based on the conditions elsewhere and the direction of the prevailing wind, a meteorologist can give the public a pretty good idea of what to expect in the near ...
Oct 10, 2017
0
1
Emerging viruses can adversely affect women's health, leading to an increase in both complications and deaths during pregnancy, childbirth and the puerperium. This is indicated by a population-based natural experiment on ...
Nov 29, 2021
0
4
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza ...
May 17, 2013
1
0
